Rationale: Myo-inositol is an isomer of glucose that is a precursor in the
phosphatidylinositol (PIP) cycle, a source of two second messengers: diacyl
glycerol (DAG) and inositol triphosphate (IP3). Clinical studies have repor
ted that inositol is effective in relieving symptoms of depression. Objecti
ve: The present study examined the effects of inositol on two animal models
of depression: the Porsolt forced swim test, a behaviorally based model; a
nd the reserpine-induced immobility model, a pharmacologically based model.
Methods and results: Chronic inositol injections (daily for 14 days) of 1.
2 g/kg (but not at lower doses) reduced immobility time and increased strug
gle time in the Porsolt test compared with control animals. The same dose a
nd treatment schedule also reduced complete immobility time but did not aff
ect ambulatory activity in the reserpine test compared with controls. Chron
ic oral treatment with inositol (10% in food for 14 days) had effects simil
ar to IP inositol in the Porsolt test. Conclusions: The effect of inositol
in animal models of depression supports its possible importance as a new tr
eatment for the disorder, and permits research on its mechanisms of action.